60 related articles for article (PubMed ID: 1722980)
1. A disorganized increase of galanin-like immunoreactivity in cerebral cortex of Alzheimer-type dementia brains.
Minami M; Makino Y; Arai H; Iizuka R
J Neural Transm Park Dis Dement Sect; 1991; 3(4):285-92. PubMed ID: 1722980
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia.
Minami M; Kimura M; Iwamoto N; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):509-13. PubMed ID: 7624501
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains.
Jafferali S; Dumont Y; Sotty F; Robitaille Y; Quirion R; Kar S
Synapse; 2000 Dec; 38(4):450-9. PubMed ID: 11044892
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain.
Stenfors C; Theodorsson E; Mathé AA
J Neurosci Res; 1989 Nov; 24(3):445-50. PubMed ID: 2480456
[TBL] [Abstract][Full Text] [Related]
5. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
6. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Oct; 47(4):1295-301. PubMed ID: 3018166
[TBL] [Abstract][Full Text] [Related]
8. Changes in benzodiazepine receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
Ann Neurol; 1988 Apr; 23(4):404-6. PubMed ID: 2837978
[TBL] [Abstract][Full Text] [Related]
9. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
10. Substance P immunoreactivity in Alzheimer disease: a study in cases presenting symmetric or asymmetric cortical atrophy.
Bouras C; Vallet PG; Hof PR; Charnay Y; Golaz J; Constantinidis J
Alzheimer Dis Assoc Disord; 1990; 4(1):24-34. PubMed ID: 1690554
[TBL] [Abstract][Full Text] [Related]
11. Increased galanin receptor occupancy in Alzheimer's disease.
McMillan PJ; Peskind E; Raskind MA; Leverenz JB
Neurobiol Aging; 2004; 25(10):1309-14. PubMed ID: 15465628
[TBL] [Abstract][Full Text] [Related]
12. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
[TBL] [Abstract][Full Text] [Related]
13. Galanin and galanin receptors in human gliomas.
Berger A; Santic R; Almer D; Hauser-Kronberger C; Huemer M; Humpel C; Stockhammer G; Sperl W; Kofler B
Acta Neuropathol; 2003 Jun; 105(6):555-60. PubMed ID: 12734662
[TBL] [Abstract][Full Text] [Related]
14. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.
Simpson IA; Chundu KR; Davies-Hill T; Honer WG; Davies P
Ann Neurol; 1994 May; 35(5):546-51. PubMed ID: 8179300
[TBL] [Abstract][Full Text] [Related]
15. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.
Chan-Palay V; Lang W; Allen YS; Haesler U; Polak JM
J Comp Neurol; 1985 Aug; 238(4):390-400. PubMed ID: 2413088
[TBL] [Abstract][Full Text] [Related]
16. Galanin-like immunoreactive expression in the central nervous system of the toad.
González Nicolini V; Orezzoli AA; Achi MV; Villar MJ; Tramezzani JH
Biocell; 1995 Aug; 19(2):95-111. PubMed ID: 7550577
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
[TBL] [Abstract][Full Text] [Related]
18. Galanin immunoreactivity and 125I-galanin binding sites in the blowfly brain.
Lundquist CT; Johard HA; Rökaeus A; Nässel DR
Acta Biol Hung; 1993; 44(1):51-4. PubMed ID: 7684173
[TBL] [Abstract][Full Text] [Related]
19. Extrahypophyseal distribution of alpha-melanocyte stimulating hormone (alpha-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer-type dementia patients.
Arai H; Moroji T; Kosaka K; Iizuka R
Brain Res; 1986 Jul; 377(2):305-10. PubMed ID: 3524751
[TBL] [Abstract][Full Text] [Related]
20. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
